P. L. Jager

1.6k total citations · 1 hit paper
25 papers, 1.2k citations indexed

About

P. L. Jager is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, P. L. Jager has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in P. L. Jager's work include Medical Imaging Techniques and Applications (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). P. L. Jager is often cited by papers focused on Medical Imaging Techniques and Applications (6 papers), Cardiac Imaging and Diagnostics (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). P. L. Jager collaborates with scholars based in Netherlands and United States. P. L. Jager's co-authors include Elisabeth G.E. de Vries, Marjolijn N. Lub–de Hooge, Johan R. de Jong, Adrienne H. Brouwers, Guus AMS van Dongen, Thijs H. Oude Munnink, Carolina P. Schröder, Eli Dijkers, Jos G. W. Kosterink and D.A. Piers and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics and Annals of Surgical Oncology.

In The Last Decade

P. L. Jager

23 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

2010 634 citations Eli Dijkers, Thijs H. Oude Munnink et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. L. Jager Netherlands	14	606	499	251	247	132	25	1.2k
June‐Key Chung South Korea	24	704 1.2×	328 0.7×	235 0.9×	312 1.3×	87 0.7×	58	1.4k
Rosa Fonti Italy	23	387 0.6×	560 1.1×	489 1.9×	276 1.1×	150 1.1×	65	1.6k
Sze Ting Lee Australia	20	633 1.0×	335 0.7×	128 0.5×	428 1.7×	102 0.8×	69	1.2k
Katharina Lückerath Germany	23	523 0.9×	922 1.8×	459 1.8×	403 1.6×	199 1.5×	51	1.7k
Jens Sørensen Sweden	23	1.1k 1.8×	592 1.2×	407 1.6×	440 1.8×	176 1.3×	80	1.9k
Somali Gavane United States	10	304 0.5×	348 0.7×	215 0.9×	269 1.1×	80 0.6×	22	1.1k
Jianjun Liu China	18	510 0.8×	317 0.6×	177 0.7×	313 1.3×	77 0.6×	68	1.0k
Andrei Todica Germany	21	840 1.4×	384 0.8×	166 0.7×	460 1.9×	243 1.8×	105	1.5k
Deborah Mulford United States	14	350 0.6×	316 0.6×	307 1.2×	225 0.9×	109 0.8×	36	967
Knut Håkon Hole Norway	20	451 0.7×	351 0.7×	285 1.1×	345 1.4×	48 0.4×	51	1.2k

Countries citing papers authored by P. L. Jager

Since Specialization

Citations

This map shows the geographic impact of P. L. Jager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. L. Jager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. L. Jager more than expected).

Fields of papers citing papers by P. L. Jager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. L. Jager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. L. Jager. The network helps show where P. L. Jager may publish in the future.

Co-authorship network of co-authors of P. L. Jager

This figure shows the co-authorship network connecting the top 25 collaborators of P. L. Jager. A scholar is included among the top collaborators of P. L. Jager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. L. Jager. P. L. Jager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dijk, J.D. van, P. L. Jager, J. P. Ottervanger, et al.. (2015). Minimizing Patient-Specific Tracer Dose in Myocardial Perfusion Imaging Using CZT SPECT. Journal of Nuclear Medicine Technology. 43(1). 36–40. 18 indexed citations

Dijkers, Eli, Thijs H. Oude Munnink, Jos G. W. Kosterink, et al.. (2010). Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer. Clinical Pharmacology & Therapeutics. 87(5). 586–592. 634 indexed citations breakdown →

Hazenberg, Bouke P. C., M. H. van Rijswijk, Marjolijn N. Lub–de Hooge, et al.. (2007). Diagnostic Performance and Prognostic Value of Extravascular Retention of 123I-Labeled Serum Amyloid P Component in Systemic Amyloidosis. Journal of Nuclear Medicine. 48(6). 865–872. 38 indexed citations

Doting, M. H. Edwina, M. de Vries, J. T. Plukker, et al.. (2007). Response: The value of sentinel lymph node biopsy in the management of head and neck melanoma. Journal of Surgical Oncology. 95(6). 523–523. 1 indexed citations

Elsinga, P. H., et al.. (2005). Positron emission tomography in patients with breast cancer using 18F-3′-deoxy-3′-fluoro-l-thymidine (18F-FLT)—a pilot study. European Journal of Surgical Oncology. 32(1). 39–43. 49 indexed citations

Maguire, R. P., et al.. (2005). Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 33(2). 200–209. 69 indexed citations

Koopmans, Klaas Pieter, et al.. (2005). 18F-DOPA PET superior for staging of neuroendocrine tumors. Journal of Clinical Oncology. 23(16_suppl). 4085–4085. 1 indexed citations

Slart, Riemer H. J. A., Jeroen J. Bax, Ernst E. van der Wall, et al.. (2005). Nuclear cardiac imaging for the assessment of myocardial viability.. PubMed. 13(11). 408–415.

Hazenberg, Bouke P. C., Ingrid I. van Gameren, Johan Bijzet, P. L. Jager, & M. H. van Rijswijk. (2004). Diagnostic and therapeutic approach of systemic amyloidosis.. PubMed. 62(4). 121–8. 50 indexed citations

10.

Broersma, Mirjam, et al.. (2004). Sentinel Node Detection in Patients With Breast Cancer. Clinical Nuclear Medicine. 29(10). 609–613. 2 indexed citations

11.

Slart, Riemer H. J. A., et al.. (2004). Different Splenic Uptake of Tc-99m Sulfur Colloid and Tc-99m Heat-Denatured Red Blood Cells in an Infant With Complete Situs Inversus. Clinical Nuclear Medicine. 29(9). 590–591. 8 indexed citations

12.

Hullu, Joanne A. de, Maaike H.M. Oonk, Anca C. Ansink, et al.. (2004). Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecologic Oncology. 94(1). 10–15. 53 indexed citations

13.

Vegt, Bert van der, M. H. Edwina Doting, P. L. Jager, Jelle Wesseling, & Jakob de Vries. (2004). Axillary recurrence after sentinel lymph node biopsy. European Journal of Surgical Oncology. 30(7). 715–720. 28 indexed citations

14.

Slart, Riemer H. J. A., et al.. (2003). Gated blood-pool SPECT automated versus manual left ventricular function calculations. Nuclear Medicine Communications. 25(1). 75–80. 5 indexed citations

15.

Slart, Riemer H. J. A., et al.. (2003). Evaluation of right ventricular function by NuSMUGA software: gated blood-pool SPECT vs. first-pass radionuclide angiography. International journal of cardiac imaging. 19(5). 401–407. 5 indexed citations

16.

Doting, M. H. Edwina, H.J. Hoekstra, John Th. M. Plukker, et al.. (2002). Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. European Journal of Surgical Oncology. 28(6). 673–678. 63 indexed citations

17.

Koopal, S A, A.T.M.G. Tiebosch, P. L. Jager, et al.. (2002). New diagnostic techniques in staging in the surgical treatment of cutaneous malignant melanoma. European Journal of Surgical Oncology. 28(7). 692–700. 15 indexed citations

18.

Roeloffzen, Wilfried, et al.. (2002). [Acute acalculous cholecystitis: not only in the intensive care department].. PubMed. 146(28). 1305–8.

19.

Hew, J. M., et al.. (2000). Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma. Clinical Endocrinology. 52(5). 653–659. 53 indexed citations

20.

Jager, P. L., E. J. F. Franssen, Ben G. Szabó, et al.. (1998). Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors.. PubMed. 39(10). 1736–43. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact